
Pacixone S 250mg/125mg Injection
Marketer
Adchem Biotech
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Pacixone S 250mg/125mg Injection
Combiflox 250mg/125mg injection is a dual-action antibiotic used to combat a range of bacterial infections. Its mechanism inhibits bacterial proliferation, thereby controlling infection spread. Administration must always be under medical guidance; strict adherence to the prescribed dosage schedule is crucial. Complete the full course of treatment, regardless of symptom improvement, as premature cessation can compromise effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects require immediate medical attention. Seek immediate medical help for allergic reactions such as rashes, itching, swelling, or breathing difficulties. Inform your physician of all current medications before initiating treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration promote faster recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Pacixone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Pacixone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pacixone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Pacixone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pacixone S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Pacixone S 250mg/125mg Injection, offer a dual-action approach to bacterial infections. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements this by countering bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Pacixone S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Pacixone S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; however, clinical data from human studies are scarce.
Breast feedingCAUTION
Administering Pacixone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Pacixone S 250mg/125mg Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Pacixone S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should receive Pacixone S 250mg/125mg Injection cautiously, with potential dose modification. Medical advice is recommended. Dosage alterations for Pacixone S 250mg/125mg Injection are unnecessary in individuals exhibiting mild or moderate liver dysfunction.
What if you forget to take Pacixone S 250mg/125mg Injection :
Omit a dose of Pacixone S 250mg/125mg Injection? Seek medical advice immediately.
Facts to Know About Pacixone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Antimicrobial agents |
